MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/14767058.2026.2675076

Медицинская библиотека · The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2026

Early first-trimester CMV screening in a regional perinatal network: a multicenter descriptive study.

Collin-Bund Virginie, Pierrat Mathilde, Zilliox Marie, Minella Chris, Begusic Nathan, Montoya Yohny, Mersch Véronique, Sananès Nicolas, Arnalsteen Charlotte, Weingertner Anne-Sophie

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеПеревод в очереди

Аннотация

INTRODUCTION

Congenital cytomegalovirus (CMV) infection remains the most common congenital infection worldwide. The implementation of systematic first-trimester CMV screening during pregnancy has been widely debated. In June 2025, the French National Authority for Health recommended nationwide screening in pregnant women. This study aimed to describe maternal-fetal transmission, neonatal infection, and pregnancy outcomes following the implementation of early CMV screening within a regional perinatal network prior to national adoption.

MATERIALS AND

METHODS

We conducted a retrospective multicenter observational study in three maternity units in Alsace between April 2021 and November 2023. Eligible patients had a primary CMV infection diagnosed periconceptionally or during the first trimester, based on serological screening performed up to 14 weeks of gestation. The primary objective of this study was to describe maternal-fetal transmission rates and neonatal outcomes following first-trimester CMV screening within a regional perinatal network. Secondary objectives included describing antenatal management strategies, including valaciclovir use, and pregnancy outcomes.

RESULTS

Thirty-eight patients with primary CMV infection were identified among 29,657 deliveries during the study period. Valaciclovir was administered in 47% of cases. Amniocentesis was performed in 68% of patients, with three positive results. Neonatal CMV testing was available in 80% of live births. Three newborns tested positive for CMV at birth, and one pregnancy was medically terminated due to confirmed CMV infection. The overall rate of congenital CMV infection among infected mothers was 10.5%.

CONCLUSION

Early CMV screening enabled identification and management of primary maternal infection in routine practice. However, the descriptive design and limited sample size preclude conclusions regarding clinical effectiveness or impact on vertical transmission.

Для цитирования: Collin-Bund Virginie, Pierrat Mathilde, Zilliox Marie, Minella Chris, Begusic Nathan, Montoya Yohny, Mersch Véronique, Sananès Nicolas, Arnalsteen Charlotte, Weingertner Anne-Sophie. Early first-trimester CMV screening in a regional perinatal network: a multicenter descriptive study.. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2026. DOI: 10.1080/14767058.2026.2675076.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.